What is Nirmatrelvir/Ritonavir combination?

Nematrelvir/Ritonavir combination (Nirmatrelvir/Ritonavir) is a drug approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with mild to moderate novel coronavirus infection and adults who are at high risk of progression to severe novel coronavirus infection, including hospitalization or death. However, the nematvir/ritonavir tablet combination is not approved or authorized for use as a pre-exposure or post-exposure prophylaxis drug to prevent novel coronavirus infection.

The Nematrelvir/Ritonavir tablet combination contains two drugs, Nirmatrelvir and Ritonavir, marketed and sold under the trade namePaxlovid and provided under Emergency Use Authorization (EUA) . Nematrevir/ritonavir administered together can help slow down its metabolism, allowing it to remain active at higher concentrations in the body for a longer period of time to help fight the virus. Patients should take the nematvir/ritonavir tablet combination as soon as possible after being diagnosed with novel coronavirus infection. The purpose is to reduce the number and severity of symptoms or to avoid serious illness that may lead to hospitalization or death.

NematrevirThe combination of nematvir/ritonavir tablets has been launched in China. Due to its short time on the market, it has not been included in the medical insurance. The domestic price has not yet been determined. The original drug of nematvir/ritonavir tablet combination marketed overseas, the specification is nematvir 150mg + ritonavir 100mg)*30 tablets per box, the price may be around 2,000 yuan (the price may fluctuate due to the exchange rate), India The price of each box of the generic Nematvir/Ritonavir tablet combination produced by the pharmaceutical factory may be around RMB 1,000 (the price may fluctuate due to the exchange rate). The ingredients of the two drugs are basically the same. For more drug information and specific prices, please consult Yaode Medical Consultant.